Expedeon develops and commercializes value-added, easy-to-use, reliable products for genomics and proteomics research for use across sample preparation, purification, characterisation, conjugation and validation.
Expedeon’s recent acquisition of world leading bioconjugation experts, Innova Biosciences, means the company is now able to offer cutting-edge antibody and protein labeling technologies and services, supporting scientists from academia through to commercial manufacturing.
The company’s product ranges are of the highest quality and are designed to streamline R&D and manufacturing processes, whilst also reducing overall project costs by cutting costs associated with e.g. material waste, QC failures, in-house equipment, and staff time, providing increased return on investment compared to traditional methods.
The company is multinational with laboratories and manufacturing facilities in the UK, USA, Spain, Germany and Singapore.